List of Supplementary Protection Certificates
Biologic Drug Supplementary Protection Certificates
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2358756 | 1791029-0 | Sweden | PRODUCT NAME: ALIROCUMAB; FIRST MARKETING AUTHORIZATION NUMBER SE: EU/1/15/1031, 2015-09-25 | ⤷ Start Trial |
| European Patent Office | 2676679 | LUC00267 | Luxembourg | PRODUCT NAME: VACCIN PNEUMOCOCCIQUE POLYOSIDIQUE CONJUGUE (15-VALENT, ADSORBE) QUI EST UNE SUSPENSION DE POLYOSIDES CAPSULAIRES ISSUE DES SEROTYPES 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F ET 33F DE S. PNEUMONIAE CONJUGUES A LA PROTEINE VECTRICE CRM197; AUTHORISATION NUMBER AND DATE: EU/1/21/1591 20211214 | ⤷ Start Trial |
| European Patent Office | 3653227 | 2022C/513 | Belgium | PRODUCT NAME: LONAPEGSOMATROPIN; AUTHORISATION NUMBER AND DATE: EU/1/21/1607 20220117 | ⤷ Start Trial |
| European Patent Office | 2649086 | 685 | Finland | ⤷ Start Trial | |
| European Patent Office | 2270045 | 1790032-5 | Sweden | PRODUCT NAME: BEZLOTOXUMAB; REG. NO/DATE: EU/1/16/1156/001-004 20170120 | ⤷ Start Trial |
| European Patent Office | 2215124 | 122016000042 | Germany | PRODUCT NAME: EVOLOCUMAB; REGISTRATION NO/DATE: EU/1/15/1016 20150717 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
